📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine. (2021)

First Author: Andreou AP

Attributed to: Sheffield CiC 2016: Addressing the funding gap to advance early stage healthcare research in Sheffield funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s13311-020-00967-7

PubMed Identifier: 33205382

Publication URI: http://europepmc.org/abstract/MED/33205382

Type: Journal Article/Review

Volume: 18

Parent Publication: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Issue: 1

ISSN: 1878-7479